Needham Lowers Price Targets on Stratasys and CorMedix
Needham cut its price target on Stratasys to $9.50 from $11.50 and on CorMedix to $12.00 from $14.00, Dow Jones Newswires reported, citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Needham has reduced its price target for Stratasys shares to $9.50 from $11.50. The same brokerage lowered its target for CorMedix to $12.00 from $14.00. Dow Jones Newswires reported both changes, drawing on Benzinga's analyst ratings data.
why it matters
Target revisions like these are routine and rarely move the broader market. For investors in these stocks, they signal a more cautious valuation from a single brokerage rather than a company-specific event.
tags
instruments
sources
- Stratasys Price Target Cut to $9.50/Share From $11.50 by Needham — Dow Jones Newswires, 13 November 2026 at 10:40 UTC
- CorMedix Price Target Cut to $12.00/Share From $14.00 by Needham — Dow Jones Newswires, 13 November 2026 at 10:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗